QLS1410 in Participants With Uncontrolled Hypertension

Clinical trial NCT07489612 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07489612
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension (HTN)

Start date: 2026-04-01
Primary completion: 2026-12-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.